Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COVI-MSC
- Development stage
- Phase 2
- Lead developer
- Sorrento Therapeutics
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
COVI-MSC (OQORY) is an investigational allogeneic adipose-derived mesenchymal stem cell (MSC) therapy developed by Sorrento Therapeutics, originally licensed from Personalized Stem Cells, Inc. (PSC). The therapy is designed to treat inflammatory lung conditions, including COVID-19-induced acute respiratory distress syndrome (ARDS), non-COVID-19 ARDS, and post-COVID-19 "long haul" pulmonary compromise. COVI-MSC works by modulating the immune response to reduce systemic inflammation and promote tissue repair, potentially mitigating the cytokine storm associated with severe respiratory distress. It is administered intravenously and has progressed into Phase 2 and Phase 3 clinical trials.
- Brand names
- OQORY
- Other names
- allogeneic adipose-derived mesenchymal stem cellsadipose-derived stem cells
Beyond the preview
Go deeper on COVI-MSC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COVI-MSC.